Article and Video CATEGORIES
Have you received a diagnosis of ovarian cancer?
GRACE is excited to have again partnered with Clinical Care Options to develop an Interactive Decision Support Tool and downloadable resource to help you understand more about your disease and treatment options, so you can become partners with your oncology team in your cancer care.
By answering multiple choice questions about your diagnosis, you will be able to review treatment options from five ovarian cancer experts listed below.
Robert L. Coleman, MD, FACOG, FACS Texas Oncology
- Thomas J. Herzog, MD UC Health
- Ursula Matulonis, MD Dana Farber/Harvard Cancer Center
- Bradley J. Monk, MD, FACOG, FACS Arizona Oncology
- Kathleen Moore, MD Stephenson Cancer Center
Clinical Care Options LLC, is a global leader in the development of innovative educational programs and technology platforms. GRACE is pleased to work with CCO on a number of patient materials and tools to help our community in their cancer journey.
The following list of decision support tools are available on our GRACE and Clinical Care Options Patient Tools partner page:
Treatment Options From 5 Experts for Patients With Ovarian Cancer
Expert Insights Interactive Decision Support Tool for Advanced NSCLC
Information Regarding Immune Checkpoint Inhibitor Therapy
Educational Video - Immunotherapy for Advanced NSCLC: Discussing Goals and Treatments With Your Health Care Provider
Expert Insights Interactive Decision Support Tool on HER2+ Early Stage Breast Cancer
Expert Insights Interactive Decision Support Tool on Melanoma
Expert Insights Interactive Decision Support Tool for Frontline Follicular Lymphoma
Educational Videos -Measurable Residual Disease (MRD) in Acute Lymphocytic Leukemia (ALL)
Please feel free to offer comments and raise questions in our
Next Previous linkPrevious PostNext Post
Hi Caregiver and welcome to Grace. I'm sorry that you need to be here and hope we can help. Osimertinib has better efficacy than gefitinib (including OS and reaching the brain)...
Hi Bob, Welcome to Grace. I'm sorry about your sil. Unfortunately, cancer becomes resistant to TKIs like tagrisso. Sometimes all of the cancer becomes resistant at once and sometimes just parts...